https://www.has-sante.fr/portail/jcms/c_2774120/fr/descovy https://www.has-sante.fr/portail/jcms/c_2774120/fr/descovy-emtricitabine-tenofovir-alafenamide-association-d-antiretroviraux 2017 false false false France French drug combinations treatment outcome emtricitabine and tenofovir alafenamide anti-hiv agents hiv infections HIV-1 human immunodeficiency virus i infection drug therapy, combination administration, oral reverse transcriptase inhibitors adult adolescent emtricitabine tenofovir alafenamide evaluation of the transparency committee insurance, health, reimbursement guidelines for drug use Emtricitabine Tenofovir adenine
--- https://www.ema.europa.eu/medicines/human/EPAR/Descovy 2016 false false false United Kingdom French English syndication feed summary of product characteristics package leaflet drug evaluation Emtricitabine drug combinations drug approval europe treatment outcome emtricitabine and tenofovir alafenamide anti-hiv agents anti-hiv agents hiv infections HIV-1 human immunodeficiency virus i infection drug therapy, combination administration, oral reverse transcriptase inhibitors reverse transcriptase inhibitors product surveillance, postmarketing drug interactions pregnancy breast feeding drug evaluation, preclinical adult adolescent emtricitabine tenofovir alafenamide emtricitabine tenofovir alafenamide Tenofovir Emtricitabine Tenofovir adenine Tenofovir